CLEC12A and acute myeloid leukemia: Taken together, we have demonstrated that CLL-1 is one of the promising surface molecules for AML diagnosis; meanwhile, CLL-1 is easy to measure in clinical practice and thus can be incorporated into the routine practice of most clinical laboratories.